First Time Loading...

Repare Therapeutics Inc
NASDAQ:RPTX

Watchlist Manager
Repare Therapeutics Inc Logo
Repare Therapeutics Inc
NASDAQ:RPTX
Watchlist
Price: 3.55 USD 0.57% Market Closed
Updated: May 18, 2024

Repare Therapeutics Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Repare Therapeutics Inc
Interest Income Expense Peer Comparison

Comparables:
ZYME
TH
FUSN
AUPH
EDT

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Repare Therapeutics Inc
NASDAQ:RPTX
Interest Income Expense
$13.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Interest Income Expense
$18.5m
CAGR 3-Years
36%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Interest Income Expense
-$8.1m
CAGR 3-Years
-19%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Interest Income Expense
$4.1m
CAGR 3-Years
131%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Interest Income Expense
$13.7m
CAGR 3-Years
157%
CAGR 5-Years
N/A
CAGR 10-Years
34%
Spectral Medical Inc
TSX:EDT
Interest Income Expense
-CA$3.2m
CAGR 3-Years
-373%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Repare Therapeutics Inc's Interest Income Expense?
Interest Income Expense
13.2m USD

Based on the financial report for Dec 31, 2023, Repare Therapeutics Inc's Interest Income Expense amounts to 13.2m USD.

What is Repare Therapeutics Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
123%

Over the last year, the Interest Income Expense growth was 123%.